Trials / Sponsors / Apollomics (Australia) Pty. Ltd.
Apollomics (Australia) Pty. Ltd.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC Hepatocellular Carcinoma, Renal Cell Carcinoma | Phase 1 / Phase 2 | 2018-09-05 |
| Completed | APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency | Phase 1 | 2017-03-27 |